VisionPoint Advisory Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
PCA
MSV
BTCPP
VFA
CAM
EB
AIM
FFA
QPBE
VisionPoint Advisory Group's LLY Position: Q3 2026 in Review
VisionPoint Advisory Group increased its Eli Lilly (LLY) stake by 3.2% in Q3 2026, buying an estimated $160K and bringing the position to 4,398 shares worth $5.09M. The position accounts for 0.8% of the portfolio, ranked #27.
VisionPoint Advisory Group first reported a position in LLY in Q2 2022 and has held it in 18 quarters since. The position peaked at $5.11M in Q2 2026. 255 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- VisionPoint Advisory Group held 4,398 shares of Eli Lilly worth $5.09M as of Q3 2026.
- VisionPoint Advisory Group bought 136 Eli Lilly shares in Q3 2026, an estimated $160K.
- Eli Lilly made up 0.8% of VisionPoint Advisory Group's portfolio in Q3 2026, its #27 holding.
- VisionPoint Advisory Group first reported a position in Eli Lilly in Q2 2022 and has held it in 18 quarters since.
- VisionPoint Advisory Group's Eli Lilly position peaked at $5.11M in Q2 2026.
- 255 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on VisionPoint Advisory Group's 13F filing for Q3 2026, filed 9 Oct 2026.